Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

SNY

Sanofi (SNY)

Sanofi

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
18/11/2024	18h23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
15/11/2024	06h59	GlobeNewswire Inc.	Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)	NASDAQ:SNY	Sanofi
06/11/2024	07h00	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis	NASDAQ:SNY	Sanofi
28/10/2024	22h56	PR Newswire (Canada)	L'immunisation par Beyfortus® pour protéger les nourrissons contre le VRS a commencé	NASDAQ:SNY	Sanofi
28/10/2024	22h54	PR Newswire (Canada)	Beyfortus® immunization to protect infants from RSV has begun	NASDAQ:SNY	Sanofi
25/10/2024	12h05	IH Market News	Capri Shares Crash 45% After Merger Block; Coursera Falls 18% on Lower Revenue Forecast	NASDAQ:SNY	Sanofi
21/10/2024	11h47	IH Market News	Spirit’s Stock Surges 56% on Refinancing; Starboard Invests in Kenvue; Cigna-Humana Merger Back in Negotiations	NASDAQ:SNY	Sanofi
17/10/2024	08h35	Business Wire	Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines	NASDAQ:SNY	Sanofi
17/10/2024	08h35	Business Wire	Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération	NASDAQ:SNY	Sanofi
16/10/2024	18h26	PR Newswire (US)	FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals	NASDAQ:SNY	Sanofi
16/10/2024	12h00	PR Newswire (US)	Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies	NASDAQ:SNY	Sanofi
11/10/2024	12h31	IH Market News	BP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and More	NASDAQ:SNY	Sanofi
27/09/2024	15h35	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD	NASDAQ:SNY	Sanofi
27/09/2024	13h00	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)	NASDAQ:SNY	Sanofi
23/09/2024	12h32	IH Market News	Apollo Eyes $5 Billion Investment in Intel; TSMC and Samsung Explore UAE Chip Projects, and More	NASDAQ:SNY	Sanofi
20/09/2024	13h45	GlobeNewswire Inc.	Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old	NASDAQ:SNY	Sanofi
16/09/2024	14h00	PR Newswire (US)	Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA	NASDAQ:SNY	Sanofi
13/09/2024	18h15	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as First and Only Treatment for Adolescents with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)	NASDAQ:SNY	Sanofi
12/09/2024	08h37	Business Wire	Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers rares	NASDAQ:SNY	Sanofi
12/09/2024	08h37	Business Wire	Sanofi, RadioMedix, and Orano Med Announce Licensing Agreement on Next-Generation Radioligand Medicine for Rare Cancers	NASDAQ:SNY	Sanofi
13/08/2024	15h06	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SNY	Sanofi
13/08/2024	12h30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SNY	Sanofi
26/07/2024	18h08	PR Newswire (Canada)	Le vaccin FluzoneMD Haute Dose Quadrivalent demeure le vaccin préférentiellement recommandé pour protéger les adultes de 65 ans et plus contre la grippe	NASDAQ:SNY	Sanofi
26/07/2024	17h17	PR Newswire (Canada)	Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza	NASDAQ:SNY	Sanofi
25/07/2024	12h19	IH Market News	Earnings Updates: Ford Shares Fall 13% on EPS Miss, Stellantis Down 6%, Viking Therapeutics Up 20%, Unilever Up 5%	NASDAQ:SNY	Sanofi
10/07/2024	22h10	PR Newswire (US)	Sanofi ships U.S. influenza vaccines for the 2024/25 season	NASDAQ:SNY	Sanofi
09/07/2024	12h54	IH Market News	BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News	NASDAQ:SNY	Sanofi
26/06/2024	23h30	GlobeNewswire Inc.	Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine	NASDAQ:SNY	Sanofi
06/06/2024	13h00	PR Newswire (US)	I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer	NASDAQ:SNY	Sanofi
31/05/2024	22h30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:SNY	Sanofi

Showing the most relevant articles for your search:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 Suivant >>

Cie de SaintGobain

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales